Carisma Therapeutics, Inc. (CARM) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Carisma Therapeutics, Inc., with annual and quarterly history.
| Metric | 2024 |
|---|---|
| Valuation | |
| P/E Ratio | -0.29x |
| P/B Ratio | -0.62x |
| P/S Ratio | 0.88x |
| Profitability | |
| Gross Margin | -204.0% |
| Operating Margin | -316.7% |
| Net Margin | -308.1% |
| EBITDA Margin | -289.5% |
| Liquidity | |
| Current Ratio | 1.48x |
| Quick Ratio | 1.48x |
| Leverage | |
| Debt/Equity | -0.09x |
YoY = year-over-year change. Source: FMP..